Skip to main content
Erschienen in: Critical Care 3/2006

01.06.2006 | Review

Year in review 2005: Critical Care – resource management

verfasst von: André Carlos Kajdacsy-Balla Amaral, Gordon D Rubenfeld

Erschienen in: Critical Care | Ausgabe 3/2006

Einloggen, um Zugang zu erhalten

Abstract

During 2005 Critical Care published several original papers dealing with resource management. Emphasis was placed on sepsis, especially the coagulation cascade, prognosis and resuscitation. The papers highlighted important aspects of the pathophysiology of coagulation and inflammation in sepsis, as well as dealing with the proper use of newly developed compounds. Several aspects of prognosis in critically ill patients were investigated, focusing on biological markers and clinical indexes. Resuscitation received great attention, dealing with the effects of fluid infusion in hemodynamics and the lung. The information obtained can be used to address unknown effects of established therapies, to enlighten current clinical discussion on controversial topics, and to introduce novel medical resources and strategies. Future clinical work will rely heavily on these preclinical and laboratory data.
Literatur
1.
Zurück zum Zitat Amaral A, Opal SM, Vincent JL: Coagulation in sepsis. Intensive Care Med 2004, 30: 1032-1040. 10.1007/s00134-004-2291-8CrossRefPubMed Amaral A, Opal SM, Vincent JL: Coagulation in sepsis. Intensive Care Med 2004, 30: 1032-1040. 10.1007/s00134-004-2291-8CrossRefPubMed
2.
Zurück zum Zitat Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, et al.: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344: 699-709. 10.1056/NEJM200103083441001CrossRefPubMed Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, et al.: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344: 699-709. 10.1056/NEJM200103083441001CrossRefPubMed
3.
Zurück zum Zitat Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler A, et al.: Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001, 286: 1869-1878. 10.1001/jama.286.15.1869CrossRefPubMed Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler A, et al.: Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001, 286: 1869-1878. 10.1001/jama.286.15.1869CrossRefPubMed
4.
Zurück zum Zitat Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, et al.: Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 2003, 290: 238-247. 10.1001/jama.290.2.238CrossRefPubMed Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, et al.: Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 2003, 290: 238-247. 10.1001/jama.290.2.238CrossRefPubMed
5.
Zurück zum Zitat de Pont AC, Bakhtiari K, Hutten BA, de Jonge E, Vroom MB, Meijers JC, Buller HR, Levi M: Recombinant human activated protein C resets thrombin generation in patients with severe sepsis – a case control study. Crit Care 2005, 9: R490-R497. 10.1186/cc3774PubMedCentralCrossRefPubMed de Pont AC, Bakhtiari K, Hutten BA, de Jonge E, Vroom MB, Meijers JC, Buller HR, Levi M: Recombinant human activated protein C resets thrombin generation in patients with severe sepsis – a case control study. Crit Care 2005, 9: R490-R497. 10.1186/cc3774PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat van 't Veer C, Mann KG: Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II. J Biol Chem 1997, 272: 4367-4377. 10.1074/jbc.272.7.4367CrossRefPubMed van 't Veer C, Mann KG: Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II. J Biol Chem 1997, 272: 4367-4377. 10.1074/jbc.272.7.4367CrossRefPubMed
7.
Zurück zum Zitat Blajchman MA, Austin RC, Fernandez-Rachubinski F, Sheffield WP: Molecular basis of inherited human antithrombin deficiency. Blood 1992, 80: 2159-2171.PubMed Blajchman MA, Austin RC, Fernandez-Rachubinski F, Sheffield WP: Molecular basis of inherited human antithrombin deficiency. Blood 1992, 80: 2159-2171.PubMed
8.
Zurück zum Zitat Klein NJ, Shennan GI, Heyderman RS, Levin M: Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils. J Cell Sci 1992, 102: 821-832.PubMed Klein NJ, Shennan GI, Heyderman RS, Levin M: Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils. J Cell Sci 1992, 102: 821-832.PubMed
9.
Zurück zum Zitat Kountchev J, Bijuklic K, Bellmann R, Wiedermann CJ, Joannidis M: Reduction of D-dimer levels after therapeutic administration of antithrombin in acquired antithrombin deficiency of severe sepsis. Crit Care 2005, 9: R596-R600. 10.1186/cc3808PubMedCentralCrossRefPubMed Kountchev J, Bijuklic K, Bellmann R, Wiedermann CJ, Joannidis M: Reduction of D-dimer levels after therapeutic administration of antithrombin in acquired antithrombin deficiency of severe sepsis. Crit Care 2005, 9: R596-R600. 10.1186/cc3808PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Levy H, Laterre PF, Bates B, Qualy RL: Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated). Crit Care 2005, 9: R502-R507. 10.1186/cc3778PubMedCentralCrossRefPubMed Levy H, Laterre PF, Bates B, Qualy RL: Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated). Crit Care 2005, 9: R502-R507. 10.1186/cc3778PubMedCentralCrossRefPubMed
11.
Zurück zum Zitat Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, Volk HD, Doecke WD, Falke KJ, Gerlach H: Immunologic and hemodynamic effects of 'low-dose' hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003, 167: 512-520. 10.1164/rccm.200205-446OCCrossRefPubMed Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, Volk HD, Doecke WD, Falke KJ, Gerlach H: Immunologic and hemodynamic effects of 'low-dose' hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003, 167: 512-520. 10.1164/rccm.200205-446OCCrossRefPubMed
12.
Zurück zum Zitat Oppert MF, Schindler RF, Husung CF, Offermann KF, Graf KJ, Boenisch O, Boenisch OF, Barckow DF, Frei UF, Eckardt KU: Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005, 33: 2457-2464. 10.1097/01.CCM.0000186370.78639.23CrossRefPubMed Oppert MF, Schindler RF, Husung CF, Offermann KF, Graf KJ, Boenisch O, Boenisch OF, Barckow DF, Frei UF, Eckardt KU: Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005, 33: 2457-2464. 10.1097/01.CCM.0000186370.78639.23CrossRefPubMed
14.
Zurück zum Zitat Hoen S, Mazoit JX, Asehnoune K, Brailly-Tabard S, Benhamou D, Moine P, Edouard AR: Hydrocortisone increases the sensitivity to alpha1-adrenoceptor stimulation in humans following hemorrhagic shock. Crit Care Med 2005, 33: 2737-2743. 10.1097/01.CCM.0000189743.55352.0ECrossRefPubMed Hoen S, Mazoit JX, Asehnoune K, Brailly-Tabard S, Benhamou D, Moine P, Edouard AR: Hydrocortisone increases the sensitivity to alpha1-adrenoceptor stimulation in humans following hemorrhagic shock. Crit Care Med 2005, 33: 2737-2743. 10.1097/01.CCM.0000189743.55352.0ECrossRefPubMed
15.
Zurück zum Zitat Vincent JL, Nadel S, Kutsogiannis DJ, Gibney RT, Yan SB, Wyss VL, Bailey JE, Mitchell CL, Sarwat S, Shinall SM, et al.: Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. Crit Care 2005, 9: R331-R343. 10.1186/cc3538PubMedCentralCrossRefPubMed Vincent JL, Nadel S, Kutsogiannis DJ, Gibney RT, Yan SB, Wyss VL, Bailey JE, Mitchell CL, Sarwat S, Shinall SM, et al.: Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. Crit Care 2005, 9: R331-R343. 10.1186/cc3538PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Afifi AA, Sacks ST, Liu VY, Weil MH, Shubin H: Accumulative prognostic index for patients with barbiturate, glutethimide and meprobamate intoxication. N Engl J Med 1971, 285: 1497-1502.CrossRefPubMed Afifi AA, Sacks ST, Liu VY, Weil MH, Shubin H: Accumulative prognostic index for patients with barbiturate, glutethimide and meprobamate intoxication. N Engl J Med 1971, 285: 1497-1502.CrossRefPubMed
17.
Zurück zum Zitat Jaimes F, Farbiarz J, Alvarez D, Martinez C: Comparison between logistic regression and neural networks to predict death in patients with suspected sepsis in the emergency room. Crit Care 2005, 9: R150-R156. 10.1186/cc3054PubMedCentralCrossRefPubMed Jaimes F, Farbiarz J, Alvarez D, Martinez C: Comparison between logistic regression and neural networks to predict death in patients with suspected sepsis in the emergency room. Crit Care 2005, 9: R150-R156. 10.1186/cc3054PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat von Dossow V, Rotard K, Redlich U, Hein OV, Spies CD: Circulating immune parameters predicting the progression from hospital-acquired pneumonia to septic shock in surgical patients. Crit Care 2005, 9: R662-R669. 10.1186/cc3826PubMedCentralCrossRefPubMed von Dossow V, Rotard K, Redlich U, Hein OV, Spies CD: Circulating immune parameters predicting the progression from hospital-acquired pneumonia to septic shock in surgical patients. Crit Care 2005, 9: R662-R669. 10.1186/cc3826PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Muller B: Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care 2005, 9: R816-R824. 10.1186/cc3885PubMedCentralCrossRefPubMed Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Muller B: Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care 2005, 9: R816-R824. 10.1186/cc3885PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Hein OV, Misterek K, Tessmann JP, van Dossow V, Krimphove M, Spies C: Time course of endothelial damage in septic shock: prediction of outcome. Crit Care 2005, 9: R323-R330. 10.1186/cc3532PubMedCentralCrossRefPubMed Hein OV, Misterek K, Tessmann JP, van Dossow V, Krimphove M, Spies C: Time course of endothelial damage in septic shock: prediction of outcome. Crit Care 2005, 9: R323-R330. 10.1186/cc3532PubMedCentralCrossRefPubMed
21.
Zurück zum Zitat Mrus JM, Braun L, Yi MS, Linde-Zwirble WT, Johnston JA: Impact of HIV/AIDS on care and outcomes of severe sepsis. Crit Care 2005, 9: R623-R630. 10.1186/cc3811PubMedCentralCrossRefPubMed Mrus JM, Braun L, Yi MS, Linde-Zwirble WT, Johnston JA: Impact of HIV/AIDS on care and outcomes of severe sepsis. Crit Care 2005, 9: R623-R630. 10.1186/cc3811PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat Fodor L, Fodor A, Ramon Y, Shoshani O, Rissin Y, Ullmann Y: Controversies in fluid resuscitation for burn management: literature review and our experience. Injury 2006, 37: 374-379. 10.1016/j.injury.2005.06.037CrossRefPubMed Fodor L, Fodor A, Ramon Y, Shoshani O, Rissin Y, Ullmann Y: Controversies in fluid resuscitation for burn management: literature review and our experience. Injury 2006, 37: 374-379. 10.1016/j.injury.2005.06.037CrossRefPubMed
23.
Zurück zum Zitat Martin GS, Eaton S, Mealer M, Moss M: Extravascular lung water in patients with severe sepsis: a prospective cohort study. Crit Care 2005, 9: R74-R82. 10.1186/cc3025PubMedCentralCrossRefPubMed Martin GS, Eaton S, Mealer M, Moss M: Extravascular lung water in patients with severe sepsis: a prospective cohort study. Crit Care 2005, 9: R74-R82. 10.1186/cc3025PubMedCentralCrossRefPubMed
24.
Zurück zum Zitat Dubin A, Murias G, Maskin B, Pozo MO, Sottile JP, Baran M, Edul VS, Canales HS, Badie JC, Etcheverry G, et al.: Increased blood flow prevents intramucosal acidosis in sheep endotoxemia: a controlled study. Crit Care 2005, 9: R66-R73. 10.1186/cc3021PubMedCentralCrossRefPubMed Dubin A, Murias G, Maskin B, Pozo MO, Sottile JP, Baran M, Edul VS, Canales HS, Badie JC, Etcheverry G, et al.: Increased blood flow prevents intramucosal acidosis in sheep endotoxemia: a controlled study. Crit Care 2005, 9: R66-R73. 10.1186/cc3021PubMedCentralCrossRefPubMed
25.
Zurück zum Zitat Kellum JA, Song M, Venkataraman R: Effects of hyperchloremic acidosis on arterial pressure and circulating inflammatory molecules in experimental sepsis. Chest 2004, 125: 243-248. 10.1378/chest.125.1.243CrossRefPubMed Kellum JA, Song M, Venkataraman R: Effects of hyperchloremic acidosis on arterial pressure and circulating inflammatory molecules in experimental sepsis. Chest 2004, 125: 243-248. 10.1378/chest.125.1.243CrossRefPubMed
26.
Zurück zum Zitat Qian T, Nieminen AL, Herman B, Lemasters JJ: Mitochondrial permeability transition in pH-dependent reperfusion injury to rat hepatocytes. Am J Physiol Cell Physiol 1997, 273: C1783-C1792. Qian T, Nieminen AL, Herman B, Lemasters JJ: Mitochondrial permeability transition in pH-dependent reperfusion injury to rat hepatocytes. Am J Physiol Cell Physiol 1997, 273: C1783-C1792.
27.
Zurück zum Zitat Vincent JL, Sakr Y, Reinhart K, Sprung CL, Gerlach H, Ranieri VM: Is albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study. Crit Care 2005, 9: R745-R754. 10.1186/cc3895PubMedCentralCrossRefPubMed Vincent JL, Sakr Y, Reinhart K, Sprung CL, Gerlach H, Ranieri VM: Is albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study. Crit Care 2005, 9: R745-R754. 10.1186/cc3895PubMedCentralCrossRefPubMed
28.
Zurück zum Zitat Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, SAFE Study Investigators: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350: 2247-2256. 10.1056/NEJMoa040232CrossRefPubMed Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, SAFE Study Investigators: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350: 2247-2256. 10.1056/NEJMoa040232CrossRefPubMed
29.
Zurück zum Zitat van Eijk LT, Pickkers P, Smits P, van den BW, Bouw MP, van der Hoeven JG: Microvascular permeability during experimental human endotoxemia: an open intervention study. Crit Care 2005, 9: R157-R164. 10.1186/cc3050PubMedCentralCrossRefPubMed van Eijk LT, Pickkers P, Smits P, van den BW, Bouw MP, van der Hoeven JG: Microvascular permeability during experimental human endotoxemia: an open intervention study. Crit Care 2005, 9: R157-R164. 10.1186/cc3050PubMedCentralCrossRefPubMed
30.
Zurück zum Zitat Fleck A, Raines G, Hawker F, Trotter J, Wallace PI, Ledingham IM, Calman KC: Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet 1985, 1: 781-784. 10.1016/S0140-6736(85)91447-3CrossRefPubMed Fleck A, Raines G, Hawker F, Trotter J, Wallace PI, Ledingham IM, Calman KC: Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet 1985, 1: 781-784. 10.1016/S0140-6736(85)91447-3CrossRefPubMed
31.
Zurück zum Zitat Margarson MP, Soni NC: Effects of albumin supplementation on microvascular permeability in septic patients. J Appl Physiol 2002, 92: 2139-2145. 10.1063/1.1495889CrossRefPubMed Margarson MP, Soni NC: Effects of albumin supplementation on microvascular permeability in septic patients. J Appl Physiol 2002, 92: 2139-2145. 10.1063/1.1495889CrossRefPubMed
32.
Zurück zum Zitat Ernest D, Belzberg AS, Dodek PM: Distribution of normal saline and 5% albumin infusions in septic patients. Crit Care Med 1999, 27: 46-50. 10.1097/00003246-199901000-00025CrossRefPubMed Ernest D, Belzberg AS, Dodek PM: Distribution of normal saline and 5% albumin infusions in septic patients. Crit Care Med 1999, 27: 46-50. 10.1097/00003246-199901000-00025CrossRefPubMed
33.
Zurück zum Zitat Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett ED: Changes in central venous saturation after major surgery, and association with outcome. Crit Care 2005, 9: R694-R699. 10.1186/cc3888PubMedCentralCrossRefPubMed Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett ED: Changes in central venous saturation after major surgery, and association with outcome. Crit Care 2005, 9: R694-R699. 10.1186/cc3888PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat Page B, Vieillard-Baron A, Chergui K, Peyrouset O, Rabiller A, Beauchet A, Aegerter P, Jardin F: Early veno-venous haemodiafiltration for sepsis-related multiple organ failure. Crit Care 2005, 9: R755-R763. 10.1186/cc3886PubMedCentralCrossRefPubMed Page B, Vieillard-Baron A, Chergui K, Peyrouset O, Rabiller A, Beauchet A, Aegerter P, Jardin F: Early veno-venous haemodiafiltration for sepsis-related multiple organ failure. Crit Care 2005, 9: R755-R763. 10.1186/cc3886PubMedCentralCrossRefPubMed
35.
Zurück zum Zitat Ratanarat R, Brendolan A, Piccinni P, Dan M, Salvatori G, Ricci Z, Ronco C: Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care 2005, 9: R294-R302. 10.1186/cc3529PubMedCentralCrossRefPubMed Ratanarat R, Brendolan A, Piccinni P, Dan M, Salvatori G, Ricci Z, Ronco C: Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care 2005, 9: R294-R302. 10.1186/cc3529PubMedCentralCrossRefPubMed
36.
Zurück zum Zitat De Waele JJ, Hoste E, Blot SI, Decruyenaere J, Colardyn F: Intra-abdominal hypertension in patients with severe acute pancreatitis. Crit Care 2005, 9: R452-R457. 10.1186/cc3754PubMedCentralCrossRefPubMed De Waele JJ, Hoste E, Blot SI, Decruyenaere J, Colardyn F: Intra-abdominal hypertension in patients with severe acute pancreatitis. Crit Care 2005, 9: R452-R457. 10.1186/cc3754PubMedCentralCrossRefPubMed
37.
Zurück zum Zitat Gao F, Melody T, Daniels DF, Giles S, Fox S: The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care 2005, 9: R764-R770. 10.1186/cc3909PubMedCentralCrossRefPubMed Gao F, Melody T, Daniels DF, Giles S, Fox S: The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care 2005, 9: R764-R770. 10.1186/cc3909PubMedCentralCrossRefPubMed
38.
Zurück zum Zitat Macias WL, Nelson DR, Williams M, Garg R, Janes J, Sashegyi A: Lack of evidence for qualitative treatment by disease severity interactions in clinical studies of severe sepsis. Crit Care 2005, 9: R607-R622. 10.1186/cc3795PubMedCentralCrossRefPubMed Macias WL, Nelson DR, Williams M, Garg R, Janes J, Sashegyi A: Lack of evidence for qualitative treatment by disease severity interactions in clinical studies of severe sepsis. Crit Care 2005, 9: R607-R622. 10.1186/cc3795PubMedCentralCrossRefPubMed
39.
Zurück zum Zitat Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL: Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004, 32: 1825-1831. 10.1097/01.CCM.0000138558.16257.3FCrossRefPubMed Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL: Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004, 32: 1825-1831. 10.1097/01.CCM.0000138558.16257.3FCrossRefPubMed
40.
Zurück zum Zitat Boerma EC, Mathura KR, van der Voort PH, Spronk PE, Ince C: Quantifying bedside-derived imaging of microcirculatory abnormalities in septic patients: a prospective validation study. Crit Care 2005, 9: R601-R606. 10.1186/cc3809PubMedCentralCrossRefPubMed Boerma EC, Mathura KR, van der Voort PH, Spronk PE, Ince C: Quantifying bedside-derived imaging of microcirculatory abnormalities in septic patients: a prospective validation study. Crit Care 2005, 9: R601-R606. 10.1186/cc3809PubMedCentralCrossRefPubMed
41.
Zurück zum Zitat Stewart PA: Modern quantitative acid-base chemistry. Can J Physiol Pharmacol 1983, 61: 1444-1461.CrossRefPubMed Stewart PA: Modern quantitative acid-base chemistry. Can J Physiol Pharmacol 1983, 61: 1444-1461.CrossRefPubMed
42.
Zurück zum Zitat O'Dell E, Tibby SM, Durward A, Aspell J, Murdoch IA: Validation of a method to partition the base deficit in meningococcal sepsis: a retrospective study. Crit Care 2005, 9: R464-R470. 10.1186/cc3760PubMedCentralCrossRefPubMed O'Dell E, Tibby SM, Durward A, Aspell J, Murdoch IA: Validation of a method to partition the base deficit in meningococcal sepsis: a retrospective study. Crit Care 2005, 9: R464-R470. 10.1186/cc3760PubMedCentralCrossRefPubMed
43.
Zurück zum Zitat Broessner G, Beer R, Franz G, Lackner P, Engelhardt K, Brenneis C, Pfausler B, Schmutzhard E: Case report: severe heat stroke with multiple organ dysfunction – a novel intravascular treatment approach. Crit Care 2005, 9: R498-R501. 10.1186/cc3771PubMedCentralCrossRefPubMed Broessner G, Beer R, Franz G, Lackner P, Engelhardt K, Brenneis C, Pfausler B, Schmutzhard E: Case report: severe heat stroke with multiple organ dysfunction – a novel intravascular treatment approach. Crit Care 2005, 9: R498-R501. 10.1186/cc3771PubMedCentralCrossRefPubMed
44.
Zurück zum Zitat Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002, 346: 557-563. 10.1056/NEJMoa003289CrossRefPubMed Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002, 346: 557-563. 10.1056/NEJMoa003289CrossRefPubMed
45.
Zurück zum Zitat Gentilello LM, Jurkovich GJ, Stark MS, Hassantash SA, O'Keefe GE: Is hypothermia in the victim of major trauma protective or harmful? A randomized, prospective study. Ann Surg 1997, 226: 439-447. 10.1097/00000658-199710000-00005PubMedCentralCrossRefPubMed Gentilello LM, Jurkovich GJ, Stark MS, Hassantash SA, O'Keefe GE: Is hypothermia in the victim of major trauma protective or harmful? A randomized, prospective study. Ann Surg 1997, 226: 439-447. 10.1097/00000658-199710000-00005PubMedCentralCrossRefPubMed
47.
Zurück zum Zitat Su F, Nguyen ND, Wang Z, Cai Y, Rogiers P, Vincent JL: Fever control in septic shock: beneficial or harmful? Shock 2005, 23: 516-520.PubMed Su F, Nguyen ND, Wang Z, Cai Y, Rogiers P, Vincent JL: Fever control in septic shock: beneficial or harmful? Shock 2005, 23: 516-520.PubMed
48.
Zurück zum Zitat Redl HR, Martin U, Khadem A, Pelinka LE, van Griensven M: Anti-L-selectin antibody therapy does not worsen the postseptic course in a baboon model. Crit Care 2005, 9: R735-R744. 10.1186/cc3825PubMedCentralCrossRefPubMed Redl HR, Martin U, Khadem A, Pelinka LE, van Griensven M: Anti-L-selectin antibody therapy does not worsen the postseptic course in a baboon model. Crit Care 2005, 9: R735-R744. 10.1186/cc3825PubMedCentralCrossRefPubMed
Metadaten
Titel
Year in review 2005: Critical Care – resource management
verfasst von
André Carlos Kajdacsy-Balla Amaral
Gordon D Rubenfeld
Publikationsdatum
01.06.2006
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 3/2006
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc4953

Weitere Artikel der Ausgabe 3/2006

Critical Care 3/2006 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.